Immuvera Therapeutics receives EMA Limited Market Authorisation and advances to registration study

Immuvera Therapeutics on the Radforsk Podcast

Patent grant strengthens Immuvera’s intellectual property portfolio

From Alv B to Immuvera Therapeutics: a name that reflects our mission

Immuvera strengthens its leadership team with seasoned Chief Technology Officer and Head of Regulatory Affairs